BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27228992)

  • 1. Treatment effects of renin-angiotensin aldosterone system blockade on kidney failure and mortality in chronic kidney disease patients.
    Vejakama P; Ingsathit A; McKay GJ; Maxwell AP; McEvoy M; Attia J; Thakkinstian A
    BMC Nephrol; 2017 Nov; 18(1):342. PubMed ID: 29187194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal safety and survival among acutely ill hospitalized patients treated by blockers of the Renin-Angiotensin axis or loop diuretics: a single-center retrospective analysis.
    Assaly M; Gorelik Y; Heyman SN; Abassi Z; Khamaisi M
    Ren Fail; 2023; 45(2):2282707. PubMed ID: 37975172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Need to continue or discontinue RAS inhibitors as CKD stage advances? Any alternative?
    Fujimoto D; Kuwabara T; Mukoyama M
    Hypertens Res; 2023 Aug; 46(8):2048-2050. PubMed ID: 37253978
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene-Diet Interactions on Metabolic Disease-Related Outcomes in Southeast Asian Populations: A Systematic Review.
    Sekar P; Ventura EF; Dhanapal ACTA; Cheah ESG; Loganathan A; Quen PL; Appukutty M; Taslim NA; Hardinsyah H; Md Noh MF; Lovegrove JA; Givens I; Vimaleswaran KS
    Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision Nephrology in Patients with Diabetes and Chronic Kidney Disease.
    Provenzano M; Maritati F; Abenavoli C; Bini C; Corradetti V; La Manna G; Comai G
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Benzofuran
    Costa GC; Montagnoli TL; Da Silva JS; de Alencar AKN; Reina Gamba LE; Alves BEO; da Silva MMC; Trachez MM; do Nascimento JHM; Pimentel-Coelho PM; Mendez-Otero R; Lima LM; Barreiro EJ; Sudo RT; Zapata-Sudo G
    Drug Des Devel Ther; 2020; 14():3337-3350. PubMed ID: 32884238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-normal albuminuria is strongly associated with incident chronic kidney disease in a nondiabetic population with normal range of albuminuria and normal kidney function.
    Okubo A; Nakashima A; Doi S; Doi T; Ueno T; Maeda K; Tamura R; Yamane K; Masaki T
    Clin Exp Nephrol; 2020 May; 24(5):435-443. PubMed ID: 32076888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight Loss Medications in the Treatment of Obesity and Hypertension.
    Cohen JB; Gadde KM
    Curr Hypertens Rep; 2019 Feb; 21(2):16. PubMed ID: 30747357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation and Functions of the Renin-Angiotensin System in White and Brown Adipose Tissue.
    Pahlavani M; Kalupahana NS; Ramalingam L; Moustaid-Moussa N
    Compr Physiol; 2017 Sep; 7(4):1137-1150. PubMed ID: 28915321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension in Obesity and the Impact of Weight Loss.
    Cohen JB
    Curr Cardiol Rep; 2017 Aug; 19(10):98. PubMed ID: 28840500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.
    Hsu TW; Liu JS; Hung SC; Kuo KL; Chang YK; Chen YC; Hsu CC; Tarng DC
    JAMA Intern Med; 2014 Mar; 174(3):347-54. PubMed ID: 24343093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of renin inhibition in treating the hypertensive patient with diabetes: a summary of preclinical and clinical evidence.
    Abdellatif AA
    Expert Rev Cardiovasc Ther; 2012 Feb; 10(2):251-63. PubMed ID: 22292880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity, Renin-Angiotensin System Blockade and Risk of Adverse Renal Outcomes: A Population-Based Cohort Study.
    Cohen JB; Stephens-Shields AJ; Denburg MR; Anderson AH; Townsend RR; Reese PP
    Am J Nephrol; 2016; 43(6):431-40. PubMed ID: 27228992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade.
    Lin CC; Wu YT; Yang WC; Tsai MJ; Liu JS; Yang CY; Li SY; Ou SM; Tarng DC; Hsu CC
    PLoS One; 2017; 12(12):e0189126. PubMed ID: 29216260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Renin-Angiotensin System Blockade on Renal Outcomes and Mortality in Pre-Dialysis Patients with Advanced Chronic Kidney Disease.
    Oh YJ; Kim SM; Shin BC; Kim HL; Chung JH; Kim AJ; Ro H; Chang JH; Lee HH; Chung W; Lee C; Jung JY
    PLoS One; 2017; 12(1):e0170874. PubMed ID: 28122064
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.